News Novel Antithrombotics and Lower Risk of Intraocular Bleeding by Medscape • 2017/12/21 • 0 Comments Novel antithrombotics such as dabigatran or rivaroxaban are associated, in some instances, with a decreased risk of intraocular hemorrhage compared with traditional anticoagulant therapy. Reuters Health Information Full Story →